默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

未开盘 04-17 16:00:00 EDT

125.37

+0.31

+0.25%

盘后125.40

+0.03+0.02%

19:45 EDT

最高126.19	最低124.71	成交量612.29万
今开125.67	昨收125.06	日振幅1.18%
总市值3,176亿	流通市值3,170亿	总股本25.33亿
成交额7.67亿	换手率0.24%	流通股本25.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":125.37,"timestamp":1713384000000,"preClose":125.06,"halted":0,"volume":6122908,"hourTrading":{"tag":"盘后","latestPrice":125.4,"preClose":125.37,"latestTime":"19:45 EDT","volume":521810,"amount":65419367.2378,"timestamp":1713397524280},"delay":0,"floatShares":2528204036,"shares":2533028189,"eps":0.14,"marketStatus":"未开盘","marketStatusCode":0,"change":0.31,"latestTime":"04-17 16:00:00 EDT","open":125.67,"high":126.19,"low":124.71,"amount":767463626.82946,"amplitude":0.011834,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.14,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713427200000},"adr":0,"listingDate":-745790400000,"adjPreClose":125.06,"adrRate":0,"dividendRate":0.023291,"preHourTrading":{"tag":"盘前","latestPrice":125.7702,"preClose":125.06,"latestTime":"09:29 EDT","volume":237,"amount":29708.20359,"timestamp":1713360553065},"postHourTrading":{"tag":"盘后","latestPrice":125.4,"preClose":125.37,"latestTime":"19:45 EDT","volume":521810,"amount":65419367.2378,"timestamp":1713397524280},"volumeRatio":0.98207,"optionData":{"bulkOrders":[{"symbol":"MRK","call":true,"expireDate":1713499200000,"strike":"125.0","timestamp":1713376812346,"price":0.8700000047683716,"volume":1350,"amount":117450,"type":"-"},{"symbol":"MRK","call":true,"expireDate":1715918400000,"strike":"125.0","timestamp":1713376812346,"price":3.5299999713897705,"volume":1350,"amount":476550,"type":"+"}]}},"requestUrl":"/m/hq/s/MRK/","defaultTab":"news","newsList":[{"id":"2426117212","title":"隔夜美股全复盘(4.12)| 三大股指盘中持续走高，苹果、英伟达均涨超4%，据报苹果计划全面更新Mac产品线，搭载增强AI功能的M4芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=2426117212","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2426117212?lang=zh_cn&edition=full","pubTime":"2024-04-12 07:30","pubTimestamp":1712878252,"startTime":"0","endTime":"0","summary":"三大股指盘中持续走高，苹果、英伟达均涨超4%，据报苹果计划全面更新Mac产品线，搭载增强AI功能的M4芯片","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/718340","is_publish_highlight":false,"gpt_icon":0},{"id":"2426846252","title":"HPV疫苗格局生变：二价跌破百元，竞对“围猎”下默沙东抢跑","url":"https://stock-news.laohu8.com/highlight/detail?id=2426846252","media":"新京报网","top":-1,"share":"https://www.laohu8.com/m/news/2426846252?lang=zh_cn&edition=full","pubTime":"2024-04-11 20:53","pubTimestamp":1712839980,"startTime":"0","endTime":"0","summary":"不过，万泰生物营收站上近年巅峰的2022年，国内HPV疫苗竞争格局变化已埋下伏笔。九价HPV疫苗赛道竞争仍在加速。万泰生物的二价HPV疫苗馨可宁获批前，国内仅有三款进口HPV疫苗，分别是葛兰素史克的二价疫苗和默沙东的四价、九价疫苗。其中，双价HPV疫苗获批签发535.31万剂，同比增长7.48%。次月，河北省疾控中心石家庄市14周岁女孩免费接种国产2价HPV疫苗项目的中标公告显示，万泰沧海、玉溪泽润二价HPV疫苗中标，货物单价为96元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411205400791feee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411205400791feee8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426588470","title":"治疗晚期胃癌！默沙东(MRK.US)与科伦博泰联合开发的TROP2靶向ADC积极临床结果公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2426588470","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426588470?lang=zh_cn&edition=full","pubTime":"2024-04-11 10:24","pubTimestamp":1712802249,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在2024年美国癌症研究协会大会上，默沙东与科伦博泰公布其所联合开发TROP2靶向抗体偶联药物芦康沙妥珠单抗用以治疗晚期胃癌或胃食管交界部癌患者2期研究的初步疗效积极结果。科伦博泰新闻稿表示，该公司目前正在计划开展一项芦康沙妥珠单抗单药治疗对比标准治疗化疗，用于3L+胃癌或食管胃交界部腺癌患者的全球3期研究。芦康沙妥珠单抗是一款靶向TROP2的ADC。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100947.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426079494","title":"默沙东下跌1.29%，报125.07美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426079494","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426079494?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:39","pubTimestamp":1712756377,"startTime":"0","endTime":"0","summary":"4月10日，默沙东(MRK)盘中下跌1.29%，截至21:39，报125.07美元/股，成交2351.74万美元。财务数据显示，截至2023年12月31日，默沙东收入总额601.15亿美元，同比增长1.4%；归母净利润3.65亿美元，同比减少97.49%。大事提醒：4月8日，默沙东获BERENBERG BANK上调目标价至143美元，最新评级Buy。4月25日，默沙东将于(美东)盘前披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/10213940188171.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426711269","title":"更新版 1-在早期研究中，Moderna疫苗显示出对头颈癌的治疗效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2426711269","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426711269?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:03","pubTimestamp":1712678602,"startTime":"0","endTime":"0","summary":"Yee说，与之前单独测试Keytruda的试验相比，这种联合疗法在延长生存期方面显示出强大的优势。周一在圣地亚哥举行的美国癌症研究协会年会上，报告了22名接受mRNA-4157疫苗与Keytruda联合治疗的患者的数据。Moderna公司表示，该疫苗组合显示出激活患者免疫反应的证据，而且在研究中发现其安全性和耐受性良好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119409","title":"BUZZ-头颈癌疫苗数据公布后，Moderna公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119409","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426119409?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:22","pubTimestamp":1712676170,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月9日 - ** Moderna   股价上涨10.3%，达到115.89美元的三个月高点** 该公司基于mRNA的癌症疫苗与默克公司  的抗癌药物Keytruda一起使用，在一项早期试验中，27.3%的头颈癌患者肿瘤缩小或消失。** 经纪公司杰富瑞（Jefferies）称，数据显示该药物有可能在皮肤癌以外的其他疾病中发挥作用** 股价今年累计上涨 14.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426860441","title":"默沙东2.08亿美元收购一家初创公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2426860441","media":"医药魔方","top":-1,"share":"https://www.laohu8.com/m/news/2426860441?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:50","pubTimestamp":1712620205,"startTime":"0","endTime":"0","summary":"近日，默沙东收购了初创公司Abceutics，这是一家从纽约州立大学布法罗分校研究员Joseph P. Balthasar博士的实验室分离出来的生物制药公司。这笔交易潜在对价高达2.08亿美元，其中包括候选药物进展的里程碑付款。2022年以来，默沙东先后引进科伦博泰、第一三共的ADC药物，大手笔进击ADC赛道。此番收购后，默沙东也将围绕ADC药物的安全性能和疗效作进一步优化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090757048b005997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090757048b005997&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426921608","title":"BUZZ-Kineta公司因早期肿瘤治疗试验结果良好而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2426921608","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426921608?lang=zh_cn&edition=full","pubTime":"2024-04-09 04:55","pubTimestamp":1712609700,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月8日 - ** 疗法开发商Kineta  盘后股价上涨~48.3%至80美分** 该公司称， (link)，其疗法KVA12123与制药商默克公司  的Keytruda联合使用后，一名唾液腺肿瘤患者出现了部分反应--癌细胞至少减少了30%。** 正在对九名登记参加试验的患者进行联合疗法测试 ** KA公司称，在对患者进行试验期间，该疗法显示出良好的安全性和耐受性** 截至上次收盘，股价在过去 12 个月下跌了 83.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2425914115","title":"默沙东下跌1.21%，报126.44美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425914115","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425914115?lang=zh_cn&edition=full","pubTime":"2024-04-08 23:28","pubTimestamp":1712590134,"startTime":"0","endTime":"0","summary":"4月8日，默沙东(MRK)盘中下跌1.21%，截至23:28，报126.44美元/股，成交1.92亿美元。财务数据显示，截至2023年12月31日，默沙东收入总额601.15亿美元，同比增长1.4%；归母净利润3.65亿美元，同比减少97.49%。大事提醒：4月25日，默沙东将于(美东)盘前披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/08232840154361.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425000346","title":"默沙东下跌1.21%，报128.33美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425000346","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425000346?lang=zh_cn&edition=full","pubTime":"2024-04-05 02:10","pubTimestamp":1712254214,"startTime":"0","endTime":"0","summary":"4月5日，默沙东(MRK)盘中下跌1.21%，截至02:10，报128.33美元/股，成交2.95亿美元。财务数据显示，截至2023年12月31日，默沙东收入总额601.15亿美元，同比增长1.4%；归母净利润3.65亿美元，同比减少97.49%。大事提醒：4月25日，默沙东将于(美东)盘前披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/05021040127732.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424924293","title":"BUZZ-eFFECTOR Therapeutics 因计划停止开发肺癌疗法而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2424924293","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424924293?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:41","pubTimestamp":1712238112,"startTime":"0","endTime":"0","summary":"    4月4日 - ** eFFECTOR Therapeutics   股价下跌78.6%至3.53美元的历史新低 ** 该公司称 ，它将停止开发用于治疗非小细胞肺癌的实验性疗法 tomivosertib** EFTR表示，虽然tomivosertib在中期研究中表现出了一定的活性，但它认为继续开发的道路并不明显。** 该公司称，tomivosertib与默克公司  的抗癌药Keytruda联用时，出现治疗突发不良事件的比例为67%，而安慰剂加Keytruda的比例为37%。** NSCLC是最常见的肺癌形式** 今年以来，股价下跌了约 69.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424814516","title":"BUZZ-Kintara Therapeutics加倍推进与TuHURA Biosciences的合并计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2424814516","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424814516?lang=zh_cn&edition=full","pubTime":"2024-04-03 20:03","pubTimestamp":1712145784,"startTime":"0","endTime":"0","summary":"    4月3日 - ** Kintara Therapeutics   股价盘前翻了一番多，达到0.21美元 ** 公司将把  与私人控股的 TuHURA Biosciences 合并，预计合并将在第三季度完成** 预计 KTRA 股东将合计拥有约 2.85% 的股份，如果达到某些里程碑，则将拥有约 5.45% 的股份，而 TuHURA 股东将合计拥有约 97.15%的股份，如果达到里程碑，则将拥有 94.55% 的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424041629","title":"默沙东下跌1.24%，报129.36美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424041629","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424041629?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:10","pubTimestamp":1712067045,"startTime":"0","endTime":"0","summary":"4月2日，默沙东(MRK)盘中下跌1.24%，截至22:10，报129.36美元/股，成交1.12亿美元。财务数据显示，截至2023年12月31日，默沙东收入总额601.15亿美元，同比增长1.4%；归母净利润3.65亿美元，同比减少97.49%。大事提醒：4月25日，默沙东将于(美东)盘前披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/02221040103230.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424743300","title":"坎托菲茨杰拉德公司：重申Merck & Co(MRK.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2424743300","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424743300?lang=zh_cn&edition=full","pubTime":"2024-04-01 21:36","pubTimestamp":1711978599,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Merck & Co(MRK.US)评级，由增持调整至增持评级,目标价135.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040121473087d0e1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040121473087d0e1f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423040131","title":"重磅新药获批 默沙东股价再创历史新高丨从华尔街到陆家嘴","url":"https://stock-news.laohu8.com/highlight/detail?id=2423040131","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2423040131?lang=zh_cn&edition=full","pubTime":"2024-03-29 10:31","pubTimestamp":1711679510,"startTime":"0","endTime":"0","summary":"重磅新药获批，默沙东股价再创历史新高。Winrevair对肺动脉高压症（PAH）患者的预期年销售额达到50亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403293029245064.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403293029245064.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422199685","title":"默沙东甲肝疫苗即将退出中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2422199685","media":"健识局","top":-1,"share":"https://www.laohu8.com/m/news/2422199685?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:56","pubTimestamp":1711630560,"startTime":"0","endTime":"0","summary":"据界面新闻3月27日报道，默沙东旗下的甲肝疫苗即将停止在中国市场的供应。在“默沙东甲肝疫苗退市”消息流出之前，有媒体曾披露这款疫苗在国内多地已经大面积缺货，近年来在国内的签发数量也逐年减少。根据默沙东2023年财报，公司在疫苗领域共布局9大产品，其中宫颈癌疫苗和水痘疫苗系列销售最好，2023年共卖出113亿美元，而甲肝疫苗总营收最低，去年销售额仅1.2亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032820565987c0c744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032820565987c0c744&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422160765","title":"默沙东重磅新药在美获批 定价14000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422160765","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2422160765?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:14","pubTimestamp":1711628063,"startTime":"0","endTime":"0","summary":"美国东部时间3月26日，默沙东宣布其用于治疗动脉性肺动脉高压（PAH）新药Winrevair获美国食品药品监督管理局(FDA)批准。消息一出，默沙东股价狂飙。截止当地时间3月27日美股收盘，默沙东每股报价131.75美元，涨幅近5%，创历史新高，总市值达3337亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202403283028142546.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202403283028142546.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422799469","title":"重磅新药获批，1瓶10万！股价狂飙，影响多大？","url":"https://stock-news.laohu8.com/highlight/detail?id=2422799469","media":"券商中国","top":-1,"share":"https://www.laohu8.com/m/news/2422799469?lang=zh_cn&edition=full","pubTime":"2024-03-28 09:10","pubTimestamp":1711588259,"startTime":"0","endTime":"0","summary":"据估计，2021年全球约4000万例PAH患者，5年内的死亡率约为43%。目前，有11款用于治疗PAH药物已获批上市，已上市的11款药物可通过促进肺血管扩张来缓解患者病情，但无法从根本上解决肺血管重塑的问题。该药物每三周注射一次，以单瓶或双瓶试剂盒形式分发。对于高昂的费用，默沙东表示，由于服用剂量根据体重计算，因此费用会因病人而异。文章来源：券商中国文章作者：周乐重磅新药获批，1瓶10万！股价狂飙，影响多大？","market":"us","thumbnail":"https://static.tigerbbs.com/fcc6dde1ecddaa17fe78079bc1ee0d48","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fcc6dde1ecddaa17fe78079bc1ee0d48"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280749277a4f96f7&s=b","is_publish_highlight":true,"gpt_icon":1},{"id":"2422992453","title":"美股三大指数集体高开 默沙东涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422992453","media":"证券时报e公司","top":-1,"share":"https://www.laohu8.com/m/news/2422992453?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:35","pubTimestamp":1711546500,"startTime":"0","endTime":"0","summary":"转自：证券时报·e公司\n\n              e公司讯，美股三大指数集体高开，道指涨0.59%，纳指涨0.67%，标普500指数涨0.59%。默沙东涨近6%，肺动脉高压药物sotatercept获FDA批准。游戏驿站跌超15%，四季度业绩不及预期。            \n\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-03-27/doc-inapusen6331770.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-03-27/doc-inapusen6331770.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0109},{"period":"1month","weight":0.0324},{"period":"3month","weight":0.0576},{"period":"6month","weight":0.2211},{"period":"1year","weight":0.0918},{"period":"ytd","weight":0.15}],"compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":-0.024},{"period":"3month","weight":0.0505},{"period":"6month","weight":0.1884},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0531}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.009892},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.000396},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.622222,"avgChangeRate":0.017947},{"month":5,"riseRate":0.659091,"avgChangeRate":0.019791},{"month":6,"riseRate":0.522727,"avgChangeRate":0.013252},{"month":7,"riseRate":0.5,"avgChangeRate":0.00548},{"month":8,"riseRate":0.477273,"avgChangeRate":0.000646},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.005533},{"month":10,"riseRate":0.545455,"avgChangeRate":0.021263},{"month":11,"riseRate":0.727273,"avgChangeRate":0.029373},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014794}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}